APPLIED GENETIC TECHNOLOGIES CORP (AGTC) [Rocket]

Overview

APPLIED GENETIC TECHNOLOGIES CORP (AGTC)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
02/14/2023	SC 13G/A	Beryl Capital Management LLC reports a 0% stake in Applied Genetic Technologies Corporation
12/12/2022	15-12G	Form 15-12G - Securities registration termination [Section 12(g)]:
12/08/2022	SC 13D	Form SC 13D - General statement of acquisition of beneficial ownership:
12/07/2022	EFFECT	Form EFFECT - Notice of Effectiveness:
12/07/2022	EFFECT	Form EFFECT - Notice of Effectiveness:
12/07/2022	EFFECT	Form EFFECT - Notice of Effectiveness:
12/01/2022	25-NSE	Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Jun-30-22	Jun-30-21	Jun-30-20	Jun-30-19	Jun-30-18	Jun-30-17	Jun-30-16	Jun-30-15
Revenues	0.3	0.5	2.5	41.7	24.2	39.5	47.4	2.4
Revenue growth	-35.0%	-79.6%	-94.1%	72.4%	-38.7%	-16.7%	1911.9%	108.5%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	0.3	0.5	2.5	41.7	24.2	39.5	47.4	2.4
Gross margin	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%	100.0%
Research and development	49.5	44.4	35.8	33.2	32.2	26.2	39.4	18.1
General and administrative	17.0	14.6	13.6	12.9	14.4	11.4	10.1	8.8
EBITA	-66.2	-58.4	-46.8	-4.2	-22.1	2.2	-1.8	-24.3
EBITA margin	-20357.8%	-11673.0%	-1908.6%	-10.1%	-91.5%	5.5%	-3.9%	-1031.5%
Amortization of intangibles	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.3
EBIT	-66.4	-58.5	-47.0	-4.4	-22.4	1.9	-2.1	-24.5
EBIT margin	-20420.9%	-11709.4%	-1915.6%	-10.5%	-92.6%	4.8%	-4.4%	-1042.1%
Pre-tax income	-68.8	-59.8	-45.8	-1.9	-21.2	2.8	-1.4	-24.3
Income taxes	0.0	-2.1	0.1	0.1	0.1	2.4	0.0	0.0
Tax rate	0.0%	3.5%				85.5%	0.0%	0.0%
Net income	-68.9	-57.8	-45.9	-2.0	-21.3	0.4	-1.4	-24.3
Net margin	-21213.2%	-11565.8%	-1870.9%	-4.8%	-88.1%	1.0%	-2.9%	-1033.1%

Diluted EPS	($1.53)	($1.77)	($2.17)	($0.11)	($1.18)	$0.02	($0.08)	($1.50)
Shares outstanding (diluted)	45.0	32.8	21.1	18.2	18.1	18.4	17.8	16.3

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.